Acknowledgments

The NIAID ClinRegs team thanks the following individuals and organizations for providing country-specific regulatory information and/or confirmations of accuracy for the ClinRegs country profiles.

Australia

  • Catherine Carey, Therapeutic and Vaccine Research Program, The Kirby Institute, UNSW Sydney
  • Jonathon Doust, Linear Clinical Research
  • Jeremy Kenner, Ethics and Integrity Section, National Health and Medical Research Council (NHMRC)
  • Therapeutic Goods Administration, Department of Health, Government of Australia

Bangladesh

  • Mary Claire Walsh, University of Vermont College of Medicine
  • Salah Uddin, Directorate General of Drug Administration (DGDA)

Brazil

  • Beatriz Grinsztejn, Instituto Nacional de Infectologia Evandro Chagas (INI) - FIOCRUZ
  • Tania Kristic, Instituto Nacional de Infectologia Evandro Chagas (INI) - FIOCRUZ
  • Sérgio Surugi de Siqueira, Pontifical Catholic University of Parana- Graduate Program of Bioethics
  • Valdilea Veloso, Instituto Nacional de Infectologia Evandro Chagas (INI) - FIOCRUZ

Canada

  • Bureau of Policy, Science and International Programs, Health Canada
  • Office of Clinical Trials, Health Canada

China

  • Chrissie Cai, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)
  • Ping Chen, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)
  • Lisa Goldfeder, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)
  • Li Zhang, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)

DRC

  • Kelly Cahill, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)
  • Nsengi Ntamabyalro, University of Kinshasa, Faculty of Medicine
  • Christelle Perdrieu, Drugs for Neglected Diseases initiative
  • Stuart Rennie, University of North Carolina-Chapel Hill, Department of Social Medicine
  • Ydrissa Sow, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)
  • Olivier Tshiani Mbaya, Leidos Biomedical Research, Inc.
  • Olaf Valverde, Drugs for Neglected Diseases initiative

Guinea

  • Jamila Aboulhab, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)
  • Oumou Younoussa Bah-Sow, Comité National d'Ethique pour la Recherche en Santé
  • Abdoul Habib Beavogui, Centre National de Formation et de Recherche en Santé Rurale de Maferinyah
  • Alexandre Delamou, Centre National de Formation et de Recherche en Santé Rurale de Maferinyah
  • Waly Diouf, Institut national de la santé et de la recherche médicale (INSERM)
  • Latifa El Hadri, United States Pharmacopeia-Global Public Health-Promoting the Quality of Medicine
  • Ydrissa Sow, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)
  • N'nah Djénab Sylla, Comité National d'Ethique pour la Recherche en Santé

India

  • Barbara Bierer, Brigham and Women's Hospital and Harvard Medical School
  • Kristan Callahan, U.S. Food and Drug Administration (USFDA), India Office
  • Nandita Chopra, National Institutes of Health (NIH)
  • Sudheendra Kulkarni, U.S. Food and Drug Administration (USFDA), India Office
  • N.Kumarasamy, Voluntary Health Services (VHS) Infectious Diseases Medical Centre (IDMC) and Chennai Antiviral Research and Treatment Clinical Research Site (CART CRS)
  • Gaurav Mathur, IQVIA
  • Sarah McMullen, U.S. Food and Drug Administration (USFDA), India Office
  • Nidhi Mehrotra, Indian Institute of Technology Kharagpur
  • Preetha Rajaraman, HHS

Kenya

  • Edward Abwao, Pharmacy and Poisons Board
  • Elizabeth Ayuo, Kenya Medical Research Institute (KEMRI)
  • Hettie Bouwer, LABCORP
  • Twanna Davis, FHI Clinical
  • Peter Odhiambo, FHI 360
  • Eileen Pouliot, Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)
  • Lydia Tuitai, Pharmacy and Poisons Board

Liberia

  • Latifa El Hadri, United States Pharmacopeia-Global Public Health-Promoting the Quality of Medicines
  • Juwe Kercula, Liberia Medicines and Health Products Regulatory Authority (LMHRA)
  • Gloria Mason, National Research Ethics Board (NREB)
  • David Sumo, Liberia Medicines and Health Products Regulatory Authority (LMHRA)
  • Jemee Tegli, University of Liberia-Pacific Institute for Research & Evaluation Africa Center

Malawi

  • Towera Banda, UNC Project Malawi
  • Hettie Bouwer, LABCORP
  • Edwin Chipala, Pharmacy, Medicines and Poisons Board
  • Mina Hosseinipour, University of North Carolina School of Medicine and UNC Project Malawi
  • Mtwalo D. Jere, Pharmacy and Medicines Regulatory Authority (PMRA)
  • Damson Kathyola, Innova Training and Development Center
  • Newton Kumwenda, Blantyre Health Research and Training Trust
  • Marybeth McCauley, FHI 360
  • Goodson Molande, Pharmacy and Medicines Regulatory Authority (PMRA)
  • Tapiwa Munthali, UNC Project Lilongwe, Malawi
  • Billy Nyambalo, National Health Sciences Research Committee, Ministry of Health
  • Terrie Taylor, Michigan State University and Blantyre Malaria Project, University of Malawi College of Medicine

Mali

  • Lindsey Beaman, Leidos Biomedical Research, Inc.
  • Elfrida Cline-Cole, Leidos Biomedical Research, Inc.
  • Seydou Doumbia, University Clinical Research Center (UCRC) University of Sciences, Techniques and Technology of Bamako
  • Fatoumata Guindo, University Clinical Research Center (UCRC) University of Sciences, Techniques and Technology of Bamako
  • Diakite Mahamadou, University Clinical Research Center (UCRC) University of Sciences, Techniques and Technology of Bamako
  • Cheick Oumar, University Clinical Research Center (UCRC), University of Sciences, Techniques and Technology of Bamako
  • Shelly Simpson, Leidos Biomedical Research, Inc.
  • Delphine Yamadjako, Leidos Biomedical Research, Inc.

Mexico

  • Mario Alanis Garza, Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS)
  • Juan Francisco Galan Herrera, La Red Mexicana de Investigación Clínica en Enfermedades Infecciosas Emergentes (LaRed)
  • Rosa Guadalupe Legaspi Jaime, Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS)
  • Abelardo Montenegro Liendo, LaRed
  • Michelle McConnell, U.S. Department of State
  • Areli Cerón Sánchez, National Bioethics Commission of Mexico (CONBIOÉTICA)
  • Mary Smolskis, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)

Peru

  • Sarah Carracedo Uribe, National Institute of Health of Peru
  • Mey León, Asociación Civil Impacta Salud y Educación
  • Roxana Lescano, Research Administration Program, US Naval Medical Research Unit No. 6 and IRB member at Pontificia Universidad Católica del Perú and Instituto de Investigación Nutricional
  • Carla Saenz, Pan American Health Organization (PAHO)
  • Jorge Sanchez, Impacta Perú and Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales
  • Hans Vasquez, Peru Clinical Trials Unit (Peru CTU)

Sierra Leone

  • Onome Abiri, Pharmacy Board of Sierra Leone
  • Pauline Akoo, London School of Hygiene & Tropical Medicine (LSHTM)
  • Latifa El Hadri, United States Pharmacopeia-Global Public Health-Promoting the Quality of Medicines
  • Eddie Foday, Sierra Leone Ministry of Health and Sanitation
  • Wiltshire Johnson, Pharmacy Board of Sierra Leone
  • Shona Lee, London School of Hygiene & Tropical Medicine (LSHTM)
  • Shelley Lees, London School of Hygiene & Tropical Medicine (LSHTM)

South Africa

  • Elizabeth Allen, Division of Clinical Pharmacology, Department of Medicine, Faculty of Health Sciences, University of Cape Town
  • Hanlie Bester, IAVI
  • Clinical HIV Research Unit, WITS Health Consortium, University of the Witwatersrand
  • HIV Prevention Clinical Trials Unit, South African Medical Research Council
  • Marzelle Haskins, Pharma-Ethics
  • Lesley Henley, Division of Paediatrics, Faculty of Health Sciences, University of Cape Town
  • Tamara Kredo, Cochrane South Africa, South African Medical Research Council
  • Nyeleti (Bicky) Mthombeni, South African Clinical Research Association (SACRA)
  • Sarita Naidoo, South African Medical Research Council
  • Duduzile Ndwandwe, Cochrane South Africa, South African Medical Research Council
  • Elizabeth Pienaar, Cochrane South Africa, South African Medical Research Council
  • Inge Vermeulen, University of Cape Town, Clinical Research Centre

Tanzania

  • Kamaka Kasssimu, Ifakara Health Institute
  • Kilimanjaro Christian Research Institute (KCRI)
  • Alambo Mssusa, Tanzania Food and Drugs Authority
  • Tooba Murshedkar, Sanaria, Inc.
  • Kissa Mwamwitwa, Tanzania Medicines and Medical Devices Authority (TMDA)

Thailand

  • Orawan Kijkuarn, FHI 360
  • Janet Robinson, FHI 360
  • Suwan Sriviriakul, FHI 360

Uganda

  • Mary Glenn Fowler, Johns Hopkins U. School of Medicine
  • Maria Musisi, Makerere U. Johns Hopkins U. Research Collaboration (MU-JHU Care LTD)
  • Clemensia Nakabiito, Makerere U. Johns Hopkins U. Research Collaboration (MU-JHU Care LTD)
  • Allan Tindikahwa, Makerere University Walter Reed Project
  • Olaf Valverde Mordt, DNDi

United Kingdom

  • Clive Collett, Health Research Authority
  • Fleur Hudson, University College London
  • Birgit Whitman, University of Birmingham

Vietnam

  • Dao Duc Giang, VietStar Biomedical Research
  • Laura Merson, Oxford University Clinical Research Unit Viet Nam
  • Janet Robinson, FHI 360
  • Loc Truong Tho, FHI 360
  • Nguyen Thi Phuong Dung, Oxford University Clinical Research Unit Viet Nam
  • Tran Thi Minh Phuong, Oxford University Clinical Research Unit Viet Nam
  • Vu Thi Lan, Oxford University Clinical Research Unit Viet Nam

Zimbabwe

  • Gift T. Chareka, University of Zimbabwe - Clinical Trials Research Centre
  • Viginia Tapfuma, University of Zimbabwe - Clinical Trials Research Centre

Page Last Updated: September 13, 2022